Advanced in Pancreatic Islet Cell Tumor

Dr. Richard A. Burkhart

Surgical Oncology | General Surgery
Johns Hopkins University
600 N Wolfe St, Blalock 266, 
Baltimore, MD 
Accepting New Patients
Offers Telehealth
17 Years of Experience
Advanced in Pancreatic Islet Cell Tumor
Johns Hopkins University
600 N Wolfe St, Blalock 266, 
Baltimore, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Richard Burkhart is a Surgical Oncologist and a General Surgeon in Baltimore, Maryland. Dr. Burkhart has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Pancreatic Islet Cell Tumor. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Burkhart is currently accepting new patients.

His clinical research consists of co-authoring 181 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Pancreatic Islet Cell Tumor.

Graduate Year
2008
Specialties
Surgical Oncology
General Surgery
Licenses
Surgery in MD
Hospital Affiliations
The Johns Hopkins Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN

Locations

JOHNS HOPKINS UNIVERSITY
600 N Wolfe St, Blalock 266, Baltimore, MD 21287
Other Locations
JOHNS HOPKINS UNIVERSITY
601 N Caroline St, Baltimore, MD 21287

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Prospective Randomized Controlled Trial Evaluating an Accelerated 5 Day Pathway for Discharge Following Pancreaticoduodenectomy (PD): Whipple Accelerated Recovery Pathway (WARP Trial)
A Prospective Randomized Controlled Trial Evaluating an Accelerated 5 Day Pathway for Discharge Following Pancreaticoduodenectomy (PD): Whipple Accelerated Recovery Pathway (WARP Trial)
Enrollment Status: Completed
Publish Date: April 30, 2025
Intervention Type: Procedure
Study Phase: Not Applicable

181 Total Publications

The Organ-Specific Prognostic Value of TP53 Mutations in Pancreatic Cancer Patients with Oligometastasis Following Surgical Resection.
The Organ-Specific Prognostic Value of TP53 Mutations in Pancreatic Cancer Patients with Oligometastasis Following Surgical Resection.
Journal: Annals of surgery
Published: July 01, 2025
Similar Doctors
Jin C. He
Distinguished in Pancreatic Islet Cell Tumor
Dr. Jin C. He
General Surgery
Distinguished in Pancreatic Islet Cell Tumor
Dr. Jin C. He
General Surgery

Johns Hopkins University

600 N Wolf St, 
Baltimore, MD 
 (0.1 miles away)
410-955-5000
Languages Spoken:
English, Mandarin
See accepted insurances
Accepting New Patients
Offers Telehealth

Jin He is a General Surgeon in Baltimore, Maryland. Dr. He is rated as an Elite provider by MediFind in the treatment of Pancreatic Islet Cell Tumor. His top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Pancreatic Ductal Adenocarcinoma, Pancreaticoduodenectomy, and Pancreatectomy. Dr. He is currently accepting new patients.

Distinguished in Pancreatic Islet Cell Tumor
Dr. John L. Cameron
General Surgery | Surgical Oncology
Distinguished in Pancreatic Islet Cell Tumor
Dr. John L. Cameron
General Surgery | Surgical Oncology
600 N Wolfe St, 
Baltimore, MD 
 (0.1 miles away)
410-955-5464
Languages Spoken:
English
See accepted insurances
Accepting New Patients

John Cameron is a General Surgeon and a Surgical Oncologist in Baltimore, Maryland. Dr. Cameron is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Islet Cell Tumor. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Islet Cell Tumor, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Cameron is currently accepting new patients.

Experienced in Pancreatic Islet Cell Tumor
Dr. Kelly J. Lafaro
Surgical Oncology | General Surgery
Experienced in Pancreatic Islet Cell Tumor
Dr. Kelly J. Lafaro
Surgical Oncology | General Surgery

Johns Hopkins University

600 N Wolfe St, Blalock 266, 
Baltimore, MD 
 (0.1 miles away)
410-502-4340
Languages Spoken:
English, Korean, Mandarin, Spanish, Vietnamese
See accepted insurances
Accepting New Patients
Offers Telehealth

Kelly Lafaro is a Surgical Oncologist and a General Surgeon in Baltimore, Maryland. Dr. Lafaro is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Islet Cell Tumor. Her top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Neuroendocrine Tumor, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Lafaro is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Burkhart's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 32 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile